1:45 PM (PT)
-
The healthcare ecosystem is experiencing an unprecedented transformation fueled by scientific, technological, geopolitical, economic, and demographic changes. Whilst breakthrough innovations are shapi ...Breakout Session
-
Emerging Opportunities in Global Markets
-
)
.jpg/fit-in/120x9999/filters:no_upscale())
)
)
)
3:00 PM (PT)
-
When Emerging Biopharma (EBP) companies consider globalization, what criteria guide their choice of markets to enter? In Japan, the evaluation of innovative new drugs has advanced significantly, creat ...Breakout Session
- Emerging Opportunities in Global Markets
-
-
In today's competitive biotech landscape, global reach is no longer a luxury—it's a prerequisite for winning. Panelists will reveal how global strategy is the defining competitive differentiator in bi ...Breakout Session
- Emerging Opportunities in Global Markets
-
)
)
)
)
)
.jpg/fit-in/120x9999/filters:no_upscale())
4:15 PM (PT)
-
The China-US relationship will have a huge role in shaping the future of global biotech. Yet, this relationship is increasingly defined by both interdependence and tension — with science, supply chain ...Breakout Session
- Emerging Opportunities in Global Markets
-
)
.jpg/fit-in/120x9999/filters:no_upscale())
4:15 PM (PT)
-
Many Western biopharma leaders look back and wish they had engaged earlier with the China story. A similar inflection point is now unfolding in Korea, and the time to engage early is now. South Korea ...Breakout Session
- Emerging Opportunities in Global Markets
-
.jpeg)
.jpg/fit-in/120x9999/filters:no_upscale())
)
12:15 PM (PT)
-
Super SessionExplore how Saudi Arabia is building an integrated biotech ecosystem: agile regulation, targeted incentives, national genomics data assets, and enabling infrastructure to become a regional and global ...Super Session
- Emerging Opportunities in Global Markets
-
)
)
1:45 PM (PT)
-
Both Secretary Kennedy and Commissioner Makary have signaled that there will be a new era of “radical transparency” at the Food and Drug Administration (FDA). Regulatory transparency is generally desi ...Breakout Session
-
Intellectual Property and Legal Landscape
-
-
This session focuses on shifting from reactive to preventative strategies in managing medicine shortages. Speakers will highlight supply chain resilience, harmonized processes and systems, and innovat ...Breakout Session
- Emerging Opportunities in Global Markets
-
)
)
)
.jpg/fit-in/120x9999/filters:no_upscale())
.jpg/fit-in/64x9999/filters:no_upscale())
)
)
)
)
)
3:00 PM (PT)
-
As pricing pressures mount in the US, pharmaceutical companies are reassessing global launch strategies. This session looks to explore how geopolitical shifts - including US policy changes, EU pharmac ...Breakout Session
- Intellectual Property and Legal Landscape
-
)
)
)
9:00 AM (PT)
-
The biopharmaceutical industry faces persistent misinformation campaigns targeting patent practices, with myths about patent thickets, evergreening, and excessive patent filings driving misguided poli ...Breakout Session
- Intellectual Property and Legal Landscape
-
)
)
)
)
10:15 AM (PT)
-
Since the first drugs were selected for “negotiation,” the Inflation Reduction Act (IRA) has been the target of litigation. Two strains of litigation emerged, with one focusing on the constitutionalit ...Breakout Session
- Intellectual Property and Legal Landscape
-
-
Europe is taking bold steps in transforming its biotech industry, from strengthening biotech ecosystems, simplifying regulatory framework, and accelerating trial authorizations, to creating better fun ...Breakout Session
- Emerging Opportunities in Global Markets
-
-
Intellectual property rights remain the foundation of innovation in the life sciences. Today, that foundation is facing sustained and coordinated pressure from all sides. Insurers, pharmacy benefit ma ...Breakout Session
- Intellectual Property and Legal Landscape
-
)
)
)
)
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}